{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T08:30:36Z","timestamp":1747125036962},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,25]]},"DOI":"10.7759\/cureus.19019","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T09:29:36Z","timestamp":1635154176000},"source":"Crossref","is-referenced-by-count":1,"title":["Infliximab Rescue in Acute Severe Ulcerative Colitis Complicated by Clostridium Difficile Infection: A Case Series"],"prefix":"10.7759","author":[{"given":"Srdjan","family":"Markovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marijana","family":"Jankovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Kalaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Branimir","family":"Zogovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Slobodan S","family":"Sreckovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.128231","article-title":"Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease","volume":"57","author":"Ananthakrishnan AN","year":"2008","unstructured":"Ananthakrishnan AN, McGinley EL, Binion DG. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut. 2008, 57:205-10. 10.1136\/gut.2007.128231","journal-title":"Gut"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1086\/651706","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA)","volume":"31","author":"Cohen SH","year":"2010","unstructured":"Cohen SH, Gerding DN, Johnson S, et al.. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010, 31:431-55. 10.1086\/651706","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.4","article-title":"Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections","volume":"108","author":"Surawicz CM","year":"2013","unstructured":"Surawicz CM, Brandt LJ, Binion DG, et al.. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013, 108:478-98. 10.1038\/ajg.2013.4","journal-title":"Am J Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2009.05.031","article-title":"Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and clostridium difficile infection","volume":"7","author":"Ben-Horin S","year":"2009","unstructured":"Ben-Horin S, Margalit M, Bossuyt P, et al.. Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and clostridium difficile infection. Clin Gastroenterol Hepatol. 2009, 7:981-7. 10.1016\/j.cgh.2009.05.031","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2016.10.024","article-title":"Management of Clostridium difficile Infection in inflammatory bowel disease: expert review from the clinical practice updates committee of the AGA institute","volume":"15","author":"Khanna S","year":"2017","unstructured":"Khanna S, Shin A, Kelly CP. Management of Clostridium difficile Infection in inflammatory bowel disease: expert review from the clinical practice updates committee of the AGA institute. Clin Gastroenterol Hepatol. 2017, 15:166-74. 10.1016\/j.cgh.2016.10.024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/136064","article-title":"Clostridium difficile infection and inflammatory bowel disease: a review","volume":"2011","author":"Sinh P","year":"2011","unstructured":"Sinh P, Barrett TA, Yun L. Clostridium difficile infection and inflammatory bowel disease: a review. Gastroenterol Res Pract. 2011, 2011:136064. 10.1155\/2011\/136064","journal-title":"Gastroenterol Res Pract"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2009.07.040","article-title":"Surgical aspects of fulminant Clostridium difficile colitis","volume":"200","author":"Butala P","year":"2010","unstructured":"Butala P, Divino CM. Surgical aspects of fulminant Clostridium difficile colitis. Am J Surg. 2010, 200:131-5. 10.1016\/j.amjsurg.2009.07.040","journal-title":"Am J Surg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12418","article-title":"European society of clinical microbiology and infectious diseases: update of the treatment guidance document for Clostridium difficile infection","volume":"20 Suppl 2","author":"Debast SB","year":"2014","unstructured":"Debast SB, Bauer MP, Kuijper EJ. European society of clinical microbiology and infectious diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect. 2014, 20 Suppl 2:1-26. 10.1111\/1469-0691.12418","journal-title":"Clin Microbiol Infect"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01305-07","article-title":"Yield of stool culture with isolate toxin testing versus a two-step algorithm including stool toxin testing for detection of toxigenic Clostridium difficile","volume":"45","author":"Reller ME","year":"2007","unstructured":"Reller ME, Lema CA, Perl TM, Cai M, Ross TL, Speck KA, Carroll KC. Yield of stool culture with isolate toxin testing versus a two-step algorithm including stool toxin testing for detection of toxigenic Clostridium difficile. J Clin Microbiol. 2007, 45:3601-5. 10.1128\/JCM.01305-07","journal-title":"J Clin Microbiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.44.3.1145-1149.2006","article-title":"Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin","volume":"44","author":"Ticehurst JR","year":"2006","unstructured":"Ticehurst JR, Aird DZ, Dam LM, Borek AP, Hargrove JT, Carroll KC. Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin. J Clin Microbiol. 2006, 44:1145-9. 10.1128\/JCM.44.3.1145-1149.2006","journal-title":"J Clin Microbiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix1085","article-title":"Clinical practice guidelines for clostridium difficile infection in adults and children: 2017 update by the infectious diseases society of America (IDSA) and society for healthcare epidemiology of America (SHEA)","volume":"66","author":"McDonald LC","year":"2018","unstructured":"McDonald LC, Gerding DN, Johnson S, et al.. Clinical practice guidelines for clostridium difficile infection in adults and children: 2017 update by the infectious diseases society of America (IDSA) and society for healthcare epidemiology of America (SHEA). Clin Infect Dis. 2018, 66:e1-e48. 10.1093\/cid\/cix1085","journal-title":"Clin Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1086\/519265","article-title":"A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity","volume":"45","author":"Zar FA","year":"2007","unstructured":"Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis. 2007, 45:302-7. 10.1086\/519265","journal-title":"Clin Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2016.9045","article-title":"Comparative effectiveness of vancomycin and metronidazole for the prevention of recurrence and death in patients with Clostridium difficile infection","volume":"177","author":"Stevens VW","year":"2017","unstructured":"Stevens VW, Nelson RE, Schwab-Daugherty EM, et al.. Comparative effectiveness of vancomycin and metronidazole for the prevention of recurrence and death in patients with Clostridium difficile infection. JAMA Intern Med. 2017, 177:546-53. 10.1001\/jamainternmed.2016.9045","journal-title":"JAMA Intern Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2018.12.007","article-title":"Fidaxomicin versus oral vancomycin for severe Clostridium difficile infection: a retrospective cohort study","volume":"25","author":"Gentry CA","year":"2019","unstructured":"Gentry CA, Nguyen PK, Thind S, Kurdgelashvili G, Skrepnek GH, Williams RJ 2nd. Fidaxomicin versus oral vancomycin for severe Clostridium difficile infection: a retrospective cohort study. Clin Microbiol Infect. 2019, 25:987-93. 10.1016\/j.cmi.2018.12.007","journal-title":"Clin Microbiol Infect"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.4947.1041","article-title":"Cortisone in ulcerative colitis; final report on a therapeutic trial","volume":"2","author":"TR SC","year":"1955","unstructured":"TR SC, WI LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955, 2:1041-8. 10.1136\/bmj.2.4947.1041","journal-title":"Br Med J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.07.024","article-title":"Reliability and initial validation of the ulcerative colitis endoscopic index of severity","volume":"145","author":"Travis SP","year":"2013","unstructured":"Travis SP, Schnell D, Krzeski P, et al.. Reliability and initial validation of the ulcerative colitis endoscopic index of severity. Gastroenterology. 2013, 145:987-95. 10.1053\/j.gastro.2013.07.024","journal-title":"Gastroenterology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/4803262","article-title":"Clostridium difficile in inflammatory bowel disease: a retrospective study","volume":"2017","author":"Gillespie W","year":"2017","unstructured":"Gillespie W, Marya N, Fahed J, Leslie G, Patel K, Cave DR. Clostridium difficile in inflammatory bowel disease: a retrospective study. Gastroenterol Res Pract. 2017, 2017:4803262. 10.1155\/2017\/4803262","journal-title":"Gastroenterol Res Pract"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1086\/430315","article-title":"Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada","volume":"40","author":"Pepin J","year":"2005","unstructured":"Pepin J, Alary ME, Valiquette L, et al.. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin Infect Dis. 2005, 40:1591-7. 10.1086\/430315","journal-title":"Clin Infect Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit346","article-title":"Is fidaxomicin worth the cost? An economic analysis","volume":"57","author":"Bartsch SM","year":"2013","unstructured":"Bartsch SM, Umscheid CA, Fishman N, Lee BY. Is fidaxomicin worth the cost? An economic analysis. Clin Infect Dis. 2013, 57:555-61. 10.1093\/cid\/cit346","journal-title":"Clin Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2012.05022.x","article-title":"Predictors of severe outcomes associated with Clostridium difficile infection in patients with inflammatory bowel disease","volume":"35","author":"Ananthakrishnan AN","year":"2012","unstructured":"Ananthakrishnan AN, Guzman-Perez R, Gainer V, et al.. Predictors of severe outcomes associated with Clostridium difficile infection in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2012, 35:789-95. 10.1111\/j.1365-2036.2012.05022.x","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/43472-infliximab-rescue-in-acute-severe-ulcerative-colitis-complicated-by-clostridium-difficile-infection-a-case-series","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:35:52Z","timestamp":1707507352000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/43472-infliximab-rescue-in-acute-severe-ulcerative-colitis-complicated-by-clostridium-difficile-infection-a-case-series"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,25]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.19019","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,25]]}}}